UPL Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

UPL hat ein Gesamteigenkapital von ₹327.1B und eine Gesamtverschuldung von ₹284.4B, wodurch sich der Verschuldungsgrad auf 87% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen ₹875.5B bzw. ₹548.4B. UPL Das EBIT des Unternehmens beträgt ₹27.5B, so dass der Zinsdeckungsgrad 0.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von ₹63.0B.

Wichtige Informationen

87.0%

Verhältnis von Schulden zu Eigenkapital

₹284.38b

Verschuldung

Zinsdeckungsgrad	0.8x
Bargeld	₹62.97b
Eigenkapital	₹327.06b
Gesamtverbindlichkeiten	₹548.40b
Gesamtvermögen	₹875.46b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 512070Die kurzfristigen Aktiva des Unternehmens (₹393.3B) übersteigen seine kurzfristigen Passiva (₹268.6B).

Langfristige Verbindlichkeiten: 512070Die kurzfristigen Vermögenswerte des Unternehmens (₹393.3B) übersteigen seine langfristigen Verbindlichkeiten (₹279.8B).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 512070Die Nettoverschuldung im Verhältnis zum Eigenkapital (67.7%) wird als hoch angesehen.

Schulden abbauen: 512070 Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 160.2% auf 87% zurückgegangen.

Schuldendeckung: 512070Die Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (6.4%) gedeckt.

Zinsdeckung: 512070Die Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (0.8x Deckung) nicht gut gedeckt.

UPL Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

UPL Limited to Report Q4, 2024 Results on May 13, 2024

UPL Limited(NSEI:UPL) dropped from Nifty 50

Price target decreased by 10% to ₹608

Now 27% undervalued after recent price drop

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued after recent price drop

Price target decreased by 8.2% to ₹698

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 19%

Price target decreased by 12% to ₹777

New major risk - Financial position

Full year 2023 earnings: EPS and revenues miss analyst expectations

UPL Limited to Report Q2, 2024 Results on Nov 14, 2023

Upcoming dividend of ₹10.00 per share at 1.6% yield

UPL Limited to Report Q1, 2024 Results on Jul 31, 2023

UPL Limited, Annual General Meeting, Aug 18, 2023

Consensus EPS estimates fall by 17%

Price target decreased by 7.3% to ₹917

UPL Limited Provides Earnings Guidance for the Year 2024

UPL Limited Recommends Dividend

Full year 2023 earnings: EPS and revenues miss analyst expectations

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Insider recently sold ₹2.7m worth of stock

Now 21% undervalued

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

UPL Limited Announces Board Changes

UPL Ltd Announces Strategic Corporate Realignment Creating Pure Play Growth Platforms

UPL Reportedly Looks to Raise $500-550 Million from PE Funds

Upl Limited Approves Final Dividend for Year Ended March 31, 2022

UPL Limited (BSE:512070) agreed to acquire 26% stake in Clean Max Kratos Pvt. Ltd. for INR 0.026 million.

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

UPL Limited to Report Q3, 2023 Results on Feb 14, 2023

UPL Limited to Report Q1, 2023 Results on Aug 01, 2022

UPL Limited, Annual General Meeting, Aug 12, 2022

UPL Limited (BSE : 512070) acquired Kudos Chemie Limited for INR 400 million.

UPL Limited Announces Launch of Flupyrimin Insecticides to Protect Rice Yields

UPL Ltd. Announces the Launch of ZOATIN, a New Biosolution

UPL Limited Recommends Dividend

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Insufficient new directors

UPL Reportedly in Merger Talks with 2 American Co.'s

UPL Limited (BSE:512070) announces an Equity Buyback for INR 11,000 million worth of its shares.

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Bunge Limited (NYSE:BG) agreed to acquire a 33% stake in SINAGRO PRODUTOS AGROPECUÁRIOS S/A from UPL Limited (BSE:512070).

Insufficient new directors

Second quarter 2022 earnings released: EPS ₹8.29 (vs ₹6.07 in 2Q 2021)

Full year 2021 earnings released: EPS ₹36.40 (vs ₹23.25 in FY 2020)

Board Member recently sold ₹3.0m worth of stock

Board Member recently sold ₹6.2m worth of stock

Additional Non-Executive & Independent Director has left the company

Full year 2021 earnings released: EPS ₹36.40 (vs ₹23.25 in FY 2020)

UPL Limited Provides Earnings Guidance for the Fiscal Year 2022

UPL Limited Recommends Dividend

Insider recently sold ₹1.3m worth of stock

AgroFresh Reaches Patent Infringement Settlement with Decco Post-Harvest, Inc. and its Parent Company, UPL Limited

FMC Corporation Announces Long-Term Collaboration with UPL Ltd. for Rynaxypyr® Active Ingredient

New 90-day high: ₹592

Revenue and earnings miss expectations

Third quarter 2021 earnings released: EPS ₹10.38 (vs ₹9.16 in 3Q 2020)

UPL Limited to Report Q3, 2021 Results on Jan 29, 2021

Investor sentiment improved over the past week

New 90-day high: ₹509

USA Court Reduces Award from $31 Million to $13 Million in A Major Relief to UPL

First half earnings released

New 90-day low: ₹433

New 90-day high - ₹530

New 90-day high - ₹519

UPL Limited to Report Q3, 2021 Results on Feb 14, 2021

First quarter earnings released

New 90-day high - ₹464

UPL Limited (BSE:512070) completed the acquisition of 75% stake in Yoloo (Laoting) Bio-technology Co., Ltd from Beijing Yoloo Bio-Technology Corp., Ltd.

UPL Limited to Report Q1, 2021 Results on Jul 31, 2020

Analyse der Finanzlage